Almoosa Health Co

SAU:4018HealthcareTADAWUL:THEItasi

——At close · Market cap — · Next earnings Wed 2 Dec

SAR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.6	0.7	0.8	1.0	1.2	1.4	1.5	+5.8%
Cost of revenue	0.4	0.5	0.6	0.7	0.8	1.0	1.0	+6.5%
Gross profit	0.2	0.2	0.2	0.3	0.4	0.4	0.5	+4.1%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	0.1	0.1	0.2	0.2	0.2	0.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.1	0.1	0.2	0.2	0.2	0.2	0.3	+15.0%
Operating income	0.1	0.1	0.1	0.1	0.2	0.2	0.2	−9.8%
Interest expense	0.0	0.0	0.0	0.0	0.1	0.0	0.1	+129.9%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−58.1%
Other income / expense	0.0	0.0	(0.0)	(0.0)	(0.1)	0.0	—	—
Pre-tax income	0.1	0.1	0.1	0.1	0.1	0.2	0.2	−15.2%
Income tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	+122.3%
Net income	0.1	0.1	0.1	0.1	0.1	0.2	0.2	−17.3%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	0.00	1.41	1.15	2.22	2.13	5.36	4.42	−17.6%
EPS, diluted (per share)	0.00	1.41	1.15	2.22	2.13	5.36	4.42	−17.6%
EBITDA	0.1	0.1	0.1	0.2	0.3	0.3	0.3	−3.7%
Depreciation & amortization	0.0	0.0	0.1	0.1	0.1	0.1	0.1	+9.3%
Weighted average shares (shares)	0	44,303,580	44,303,580	44,303,580	44,303,580	44,141,000	—	—
Weighted average diluted shares (shares)	0	44,303,580	44,303,580	44,303,580	44,303,580	44,141,000	—	—
Gross margin	35.0%	29.0%	25.9%	28.3%	30.1%	31.7%	31.2%	−0.5 pts
Operating margin	16.9%	9.5%	6.8%	11.8%	14.2%	14.5%	12.3%	−2.1 pts
Net margin	16.7%	8.9%	6.3%	10.0%	7.9%	16.7%	13.1%	−3.6 pts

SAR billionsUpdated Thu 24 Sep ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.